CAS: 2052130-80-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | H3B-6545 REF: 3D-CHD13080CAS: 2052130-80-8 | Min. 95% | To inquire | Mon 15 Jul 24 |
 | H3B-6545 REF: TM-T11530LCAS: 2052130-80-8 | - - - | 113.00 €~2,368.00 € | Mon 05 Aug 24 |
H3B-6545
CAS:2052130-80-8
H3B-6545 is an investigational drug that is a CDK4/6 inhibitor. H3B-6545 has been shown to …
Formula:
C30H29F4N5O2
Purity:
Min. 95%
Molecular weight:
567.6 g/mol
Ref: 3D-CHD13080
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
H3B-6545
CAS:2052130-80-8
H3B-6545 is an oral and selective antagonist of estrogen receptor covalent (SERCA).
Formula:
C30H29F4N5O2
Molecular weight:
567.58
Ref: TM-T11530L
| 25mg | 1,058.00 € | |
| 50mg | 1,395.00 € | |
| 100mg | 2,368.00 € |
Estimated delivery in United States, on Monday 5 Aug 2024
